Antimüllerian hormone levels decrease in women using combined contraception independently of administration route

Fertility and Sterility

Volumn 99, Issue 5, 2013, Pages 1305-1310

  Kallio, Sanna ^a   Puurunen, Johanna ^a   Ruokonen, Aimo ^a   Vaskivuo, Tommi ^a   Piltonen, Terhi ^a   Tapanainen, Juha S ^a,b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Antim llerian hormone; combined contraception; follicle development; FSH; inhibin B

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETONOGESTREL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; NORELGESTROMIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTRACEPTION; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; NORMAL HUMAN; ORAL CONTRACEPTION; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VAGINA CONTRACEPTION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-MULLERIAN HORMONE; CONTRACEPTIVE DEVICES, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; NORGESTREL; OVARIAN FOLLICLE; OXIMES; PITUITARY GLAND; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84875719108     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.11.034     Document Type: Article

References (52)

1. S.O. Skouby Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries Eur J Contracept Reprod Health Care 9 2004 57 68
2. D.R. Mishell Jr., O.A. Kletzky, P.F. Brenner, S. Roy, and J. Nicoloff The effect of contraceptive steroids on hypothalamic-pituitary function Am J Obstet Gynecol 128 1977 60 74
3. Z.M. van der Spuy, U. Sohnius, C.A. Pienaar, and R. Schall Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users Contraception 42 1990 597 609
4. M.A. Vandever, T.J. Kuehl, P.J. Sulak, I. Witt, A. Coffee, and T.J. Wincek Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens Contraception 77 2008 162 170
5. W.D. Schlaff, A.M. Lynch, H.D. Hughes, M.I. Cedars, and D.L. Smith Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression Am J Obstet Gynecol 190 2004 943 951
6. A.M. van Heusden, and B.C. Fauser Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives Contraception 59 1999 237 243
7. S.A. Willis, T.J. Kuehl, A.M. Spiekerman, and P.J. Sulak Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval Contraception 74 2006 100 103
8. J. Spona, M. Elstein, W. Feichtinger, H. Sullivan, F. Lüdicke, and U. Müller Shorter pill-free interval in combined oral contraceptives decreases follicular development Contraception 54 1996 71 77
9. H. Sullivan, H. Furniss, J. Spona, and M. Elstein Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity Fertil Steril 72 1999 115 120
10. J. Bitzer, and J.A. Simon Current issues and available options in combined hormonal contraception Contraception 84 2011 342 356
11. M.W. van den Heuvel, A.J. van Bragt, A.K. Alnabawy, and M.C. Kaptein Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive Contraception 72 2005 168 174
12. C. Weenen, J.S. Laven, A.R. Von Bergh, M. Cranfield, N.P. Groome, and J.A. Visser Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Hum Reprod 10 2004 77 83
13. I.A. van Rooij, F.J. Broekmans, E.R. te Velde, B.C. Fauser, L.F. Bancsi, and F.H. de Jong Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve Hum Reprod 17 2002 3065 3071
14. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimüllerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362
15. I.A. van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, and F.H. de Jong Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fertil Steril 83 2005 979 987
16. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. te Velde, and F.J. Broekmans Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
17. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-Müllerian hormone throughout the human menstrual cycle Hum Reprod 21 2006 3103 3107
18. D.M. Wunder, N.A. Bersinger, M. Yared, R. Kretschmer, and M.H. Birkhauser Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women Fertil Steril 89 2008 927 933
19. I. Streuli, T. Fraisse, C. Pillet, V. Ibecheole, P. Bischof, and D. de Ziegler Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Fertil Steril 90 2008 395 400
20. E. Arbo, D.V. Vetori, M.F. Jimenez, F.M. Freitas, N. Lemos, and J.S. Cunha-Filho Serum anti-müllerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills Hum Reprod 22 2007 3192 3196
21. A. Somunkiran, T. Yavuz, O. Yucel, and I. Ozdemir Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 134 2007 196 201
22. M.H. van den Berg, E. van Dulmen-den Broeder, A. Overbeek, J.W. Twisk, R. Schats, and F.E. van Leeuwen Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases Hum Reprod 25 2010 1520 1527
23. C.M. Shaw, F.Z. Stanczyk, B.L. Egleston, L.L. Kahle, C.S. Spittle, and A.K. Godwin Serum antimüllerian hormone in healthy premenopausal women Fertil Steril 95 2011 2718 2721
24. S. Deb, B.K. Campbell, C. Pincott-Allen, J.S. Clewes, G. Cumberpatch, and N.J. Raine-Fenning Quantifying the effect of the combined oral contraceptive pill on the functional ovarian reserve as measured by serum anti-Müllerian hormone and the small antral follicle count made using three-dimensional ultrasound Ultrasound Obstet Gynecol 39 2012 574 580
25. S.L. Kristensen, C.H. Ramlau-Hansen, C.Y. Andersen, E. Ernst, S.F. Olsen, and J.P. Bonde The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women Fertil Steril 97 2012 779 785
26. F. Fabregues, C. Castelo-Branco, F. Carmona, M. Guimera, R. Casamitjana, and J. Balasch The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age Gynecol Endocrinol 27 2011 216 224
27. H.W. Li, C.Y. Wong, W.S. Yeung, P.C. Ho, and E.H. Ng Serum anti-müllerian hormone level is not altered in women using hormonal contraceptives Contraception 83 2011 582 585
28. T. Piltonen, J. Puurunen, P. Hedberg, A. Ruokonen, S.J. Mutt, and K.H. Herzig Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study Hum Reprod 27 2012 3046 3056
29. A. Gougeon Dynamics of follicular growth in the human: a model from preliminary results Hum Reprod 1 1986 81 87
30. A. Gougeon Regulation of ovarian follicular development in primates: facts and hypotheses Endocrinol Rev 17 1996 121 155
31. K.A. Vendola, J. Zhou, O.O. Adesanya, S.J. Weil, and C.A. Bondy Androgens stimulate early stages of follicular growth in the primate ovary J Clin Invest 101 1998 2622 2629
32. A.A. Murray, R.G. Gosden, V. Allison, and N. Spears Effect of androgens on the development of mouse follicles growing in vitro J Reprod Fertil 113 1998 27 33
33. P. Pigny, E. Merlen, Y. Robert, C. Cortet-Rudelli, C. Decanter, and S. Jonard Elevated serum level of anti-müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest J Clin Endocrinol Metab 88 2003 5957 5962
34. C.L. Cook, Y. Siow, A.G. Brenner, and M.E. Fallat Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women Fertil Steril 77 2002 141 146
35. W.M. Baarends, J.T. Uilenbroek, P. Kramer, J.W. Hoogerbrugge, E.C. van Leeuwen, and A.P. Themmen Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth Endocrinology 136 1995 4951 4962
36. K.L. Britt, P.K. Saunders, S.J. McPherson, M.L. Misso, E.R. Simpson, and J.K. Findlay Estrogen actions on follicle formation and early follicle development Biol Reprod 71 2004 1712 1723
37. G. Chen, T. Shinka, K. Kinoshita, H.T. Yan, T. Iwamoto, and Y. Nakahori Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Müllerian inhibitory substance (MIS) promoter J Med Invest 50 2003 192 198
38. M. Grynberg, A. Pierre, R. Rey, A. Leclerc, N. Arouche, and L. Hesters Differential regulation of ovarian anti-Müllerian hormone (AMH) by estradiol through alpha- and beta-estrogen receptors J Clin Endocrinol Metab 97 2012 E1649 E1657
39. G. Liberty, A. Ben-Chetrit, E.J. Margalioth, J.H. Hyman, N. Galoyan, and T. Eldar-Geva Does estrogen directly modulate anti-müllerian hormone secretion in women? Fertil Steril 94 2010 2253 2256
40. K. Aittomäki, R. Herva, U.H. Stenman, K. Juntunen, P. Ylöstalo, and O. Hovatta Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene J Clin Endocrinol Metab 81 1996 3722 3726
41. R.B. Barnes, A.B. Namnoum, R.L. Rosenfield, and L.C. Layman The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries Hum Reprod 17 2002 88 91
42. T.R. Kumar, Y. Wang, N. Lu, and M.M. Matzuk Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility Nat Genet 15 1997 201 204
43. X.N. Wang, and G.S. Greenwald Hypophysectomy of the cyclic mouse. I. Effects on folliculogenesis, oocyte growth, and follicle-stimulating hormone and human chorionic gonadotropin receptors Biol Reprod 48 1993 585 594
44. D.M. Halpin, H.M. Charlton, and M.J. Faddy Effects of gonadotrophin deficiency on follicular development in hypogonadal (hpg) mice J Reprod Fertil 78 1986 119 125
45. N.D. Tran, M.I. Cedars, and M.P. Rosen The role of anti-müllerian hormone (AMH) in assessing ovarian reserve J Clin Endocrinol Metab 96 2011 3609 3614
46. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocrinol Rev 21 2000 200 214
47. D. Panidis, N.A. Georgopoulos, A. Piouka, I. Katsikis, A.D. Saltamavros, and G. Decavalas The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia Gynecol Endocrinol 27 2011 587 592
48. A.Z. Steiner, F.Z. Stanczyk, S. Patel, and A. Edelman Antimüllerian hormone and obesity: insights in oral contraceptive users Contraception 81 2010 245 248
49. N.P. Groome, P.J. Illingworth, M. O'Brien, R. Pai, F.E. Rodger, and J.P. Mather Measurement of dimeric inhibin B throughout the human menstrual cycle J Clin Endocrinol Metab 81 1996 1401 1405
50. S. Luisi, L.E. Borges, L. Lazzeri, A. Dell'Anna, F.M. Severi, and F. Petraglia Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness Fertil Steril 86 2006 1483 1487
51. M.A. Renier, A. Vereecken, E. Van Herck, D. Straetmans, P. Ramaekers, and J. Vanderheyden Dimeric inhibin serum values as markers of ovarian activity in pill-free intervals Contraception 57 1998 45 48
52. K.Z. Reape, C.E. DiLiberti, C.H. Hendy, and E.J. Volpe Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive Contraception 77 2008 34 39